Direct Pan-Cancer Multi-Omic Analysis of Radiotherapy Response Reveals Coding and Regulatory Genomic Variation, and Extracellular Adaptive Programs Underlying Radioresistance
Preetha Ravi, Shree Chaitranjali YadlaiD, Venkatesh KamarajiD, Karthik RamaniD
Abstract
Radioresistance remains a major barrier to effective radiotherapy, yet its molecular determinants remain incompletely understood. Most radiogenomic studies infer radioresistance using surrogate endpoints rather than from clinically annotated treatment response data. Here, we analysed genomic, transcriptomic, immune and clinical features of 1,445 radiotherapy-treated patients across 15 cancer types represented in The Cancer Genome Atlas with documented radiotherapy outcomes. Cancer-type-specific somatic association analyses identified 132 significant candidate variant associations across six cancer types, including three previously unannotated coding variants in TCF20, PTPN14, and CADM1. Functional annotation showed that radioresistant tumours were enriched for cytoplasmic, protein-associated, and metabolic functions, whereas radiosensitive tumours were enriched for nuclear regulatory programs. Through transcriptomic analysis, we identified 107 differentially expressed genes across 8 cancer types, enriched for extracellular signalling, secretory programs, and tumour-microenvironment interactions. The genomic and transcriptomic analyses revealed a limited gene overlap but converged on cellular adaptation and survival. Together, our findings suggest that radioresistance is characterised by complementary adaptive processes, whereby intracellular protein-regulatory and metabolic processes are coupled with extracellular signalling and tumour-microenvironment interactions. Clinically, radioresistance was associated with significantly poorer overall survival, whereas the radiosensitivity index and inferred tumour immune composition showed limited concordance with observed treatment response. To our knowledge, this study provides the first pan-cancer characterisation of clinically defined radiotherapy response and identifies potential candidate biomarkers for functional validation. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=131 SRC="FIGDIR/small/26363823v1_ufig1.gif" ALT="Figure 1"> View larger version (51K): org.highwire.dtl.DTLVardef@f5c8fborg.highwire.dtl.DTLVardef@5dfb22org.highwire.dtl.DTLVardef@128f03org.highwire.dtl.DTLVardef@6b2ab7_HPS_FORMAT_FIGEXP M_FIG C_FIG Created in BioRender. Yadla, S. C. (2026) https://BioRender.com/6jm1crm
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Pre-existing Subclones Determine Radioresistance in Rectal Cancer Organoids
D. Andel, B. Viergever, … O. Kranenburg·bioRxiv·Nov 2, 2023
- Harnessing tumor immune ecosystem dynamics to personalize radiotherapy
G. D. Grass, J. C. Lopez Alfonso, … J. Torres Roca·bioRxiv·Feb 11, 2020
- Genomic-Adjusted Radiation Dose from Bulk RNA Sequencing for Personalized Radiotherapy
Drew T. Bergman, Jill Durkin, … Jacob G. Scott·bioRxiv·May 30, 2026
- CPT1A Mediates Radiation Sensitivity in Colorectal Cancer
Zhenhui Chen, Lu Yu, … Yi� Ding·eLifePeer-reviewed·Aug 7, 2024
- Targeting CD73-A2aR-Mediated Adenosine Signaling at the Tumor-Immune Interface Overcomes Radioresistance
Shruti Bansal, Luis Aparicio, … Catherine S. Spina·bioRxiv·May 29, 2026
- High complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance
Anne Wursthorn, Christian Schwager, … Ali Nowrouzi·International Journal of CancerPeer-reviewed·Oct 27, 2021